The secure aggregation of data from different sources could potentially benefit the health technology field in Finland. Here in this short blog and video, Minna Hendolin, Director at Business Finland explains why personalised medicine and gene technology is central to a new personalised health initiative.
The programme will also help growth companies raise venture capital and R&D funding as well as developing new knowledge and attracting international venture capital and business units to Finland.
We hope that this ecosystem will grow and that new companies will join us to work more effectively in healthcare and well-being.
This is the fourth part of Sitra’s series of videos and blogs for Precision Medicine Forum. The first, by Sitra’s Project Director, Digital Health Hub, Jaana Sinipuro can be viewed here, the second by Hannu Hämäläinen, Ministerial Adviser, Ministry of Social Affairs and Health can be viewed here and the third from Johanna Arola, Acting CEO at FinBioBank can be viewed here.
Jaana Sinipuro from Sitra will be speaking at the Nordic Precision Medicine Forum next week in Copenhagen. You can still register for the event here.